CLOs on the Move

QIG Group

www.qiggroup.com

 
QIG Group is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.qiggroup.com
  • 10675 Naples St NE
    Minneapolis, MN USA 55449
  • Phone: 763.786.7400

Executives

Name Title Contact Details

Similar Companies

Blessing Hospital

Blessing Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Blessing Hospital is based in Quincy, IL. You can find more information on Blessing Hospital at www.blessinghospital.com

Healthy Environments

Healthy Environments is a Mooresville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SonderMind

SonderMind makes it easier for people who are searching for a mental health professional to find licensed therapists who are available for in-person or video sessions.

National Kidney Registry

The National Kidney Registry is a national registry in the United States listing kidney donors and recipients in need of a kidney transplant.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.